← All companies

HOWL

Werewolf Therapeutics, Inc.

HOWL Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.37

-0.13 -26.48%

Key statistics

from XBRL data in SEC filings

Market cap

$17.9M

Revenue (TTM)

—

Net income (TTM)

-$34.6M

EPS (TTM)

$-0.73

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$22.0M

Total assets

$24.2M

Gross margin

—

52-week range

$0.27 – $2.38

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 31, 2026 8-K Results of operations (earnings release) Jul 31, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 27, 2026 8-K Other events Feb 24, 2026 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure Feb 13, 2026 8-K Delisting notice or listing-rule failure Feb 6, 2026 8-K Other events Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Delisting notice or listing-rule failure Oct 6, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 13, 2025 8-K Delisting notice or listing-rule failure May 15, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Director or officer change Feb 24, 2025 8-K Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Other events Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure; Other events Jun 25, 2024 8-K Regulation FD disclosure; Other events Jun 3, 2024 8-K Shareholder vote results May 28, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024 8-K Results of operations (earnings release) May 3, 2024 10-K Fiscal year ended 2023-12-31 Mar 7, 2024 8-K Results of operations (earnings release); Director or officer change Mar 7, 2024 8-K Other events Feb 9, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Director or officer change Jan 4, 2024 8-K Results of operations (earnings release) Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Regulation FD disclosure; Other events Nov 3, 2023